HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$108.52
-0.21 (-0.19%)
Financial Highlights (FY 2026)
Revenue
1.34B
Net Income
97.96M
Gross Margin
59.0%
Profit Margin
7.3%
Rev Growth
+4.5%
D/E Ratio
1.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.34B 1.29B 2.17B 1.94B
Gross Profit 792.37M 758.18M 1.18B 1.05B
Operating Income 157.80M 135.89M 248.79M 212.97M
Net Income 97.96M 84.36M 171.22M 125.72M
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Rev Growth +4.5% +4.5% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.48B 1.48B 666.77M 805.22M
Total Equity 964.51M 964.51M 1.73B 1.53B
D/E Ratio 1.54 1.54 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 202.08M 183.69M 302.84M 250.08M
Free Cash Flow 163.13M 182.49M